Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mueller

Showing results (841-850 of 892) with videos related to

Pageof 90
Sort By:
Immunity|June 9, 2009
Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunitySusannah D Brydges, James L Mueller, Matthew D McGeough, et al.
Immune Network|May 11, 2026
Complement Anaphylatoxin C5a-Induced Mouse Lymphatic Functions Modulate Interactions Between Endothelial Cells and T LymphocytesHaydn E Rich, Yi-Dong Li, Kathryn D Hok, et al.
European Journal of Immunology|April 22, 2025
Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease CoursesC Dörnte, A Datsi, V Traska, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2018
Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid ArthritisPhilip J Titcombe, Gustaf Wigerblad, Natalie Sippl, et al.
Journal of Occupational and Environmental Medicine|July 3, 2014
ACOEM practice guidelines: opioids and safety-sensitive workKurt T Hegmann, Michael S Weiss, Kirk Bowden, et al.
Journal of Occupational and Environmental Medicine|November 22, 2014
ACOEM practice guidelines: opioids for treatment of acute, subacute, chronic, and postoperative painKurt T Hegmann, Michael S Weiss, Kirk Bowden, et al.
ESMO Open|July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)K Heinrich, M Karthaus, S Fruehauf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)M Moehler, A Maderer, P C Thuss-Patience, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 7, 2022
Anesthetics to Prevent Lung Injury in Cardiac Surgery: A Randomized Controlled TrialBrian P O'Gara, Shahzad Shaefi, Doris V Gasangwa, et al.
Human Mutation|November 22, 2018
EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndromeSagar J Pathak, James L Mueller, Kevin Okamoto, et al.
Pageof 90

Showing results (841-850 of 892) with videos related to

Sort By:
Pageof 90
Immunity|June 9, 2009
Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunitySusannah D Brydges, James L Mueller, Matthew D McGeough, et al.
Immune Network|May 11, 2026
Complement Anaphylatoxin C5a-Induced Mouse Lymphatic Functions Modulate Interactions Between Endothelial Cells and T LymphocytesHaydn E Rich, Yi-Dong Li, Kathryn D Hok, et al.
European Journal of Immunology|April 22, 2025
Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease CoursesC Dörnte, A Datsi, V Traska, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2018
Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid ArthritisPhilip J Titcombe, Gustaf Wigerblad, Natalie Sippl, et al.
Journal of Occupational and Environmental Medicine|July 3, 2014
ACOEM practice guidelines: opioids and safety-sensitive workKurt T Hegmann, Michael S Weiss, Kirk Bowden, et al.
Journal of Occupational and Environmental Medicine|November 22, 2014
ACOEM practice guidelines: opioids for treatment of acute, subacute, chronic, and postoperative painKurt T Hegmann, Michael S Weiss, Kirk Bowden, et al.
ESMO Open|July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)K Heinrich, M Karthaus, S Fruehauf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)M Moehler, A Maderer, P C Thuss-Patience, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 7, 2022
Anesthetics to Prevent Lung Injury in Cardiac Surgery: A Randomized Controlled TrialBrian P O'Gara, Shahzad Shaefi, Doris V Gasangwa, et al.
Human Mutation|November 22, 2018
EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndromeSagar J Pathak, James L Mueller, Kevin Okamoto, et al.
Pageof 90